Studies of pharmacokinetics in beagle dogs and drug-drug interaction potential of a novel selective ZAK inhibitor 3h for hypertrophic cardiomyopathy treatment-Reference-Cited by-同舟云学术

Studies of pharmacokinetics in beagle dogs and drug-drug interaction potential of a novel selective ZAK inhibitor 3h for hypertrophic cardiomyopathy treatment

Published:2019-08 Issue: Volume:172 Page:206-213
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Jiang Weifan,Ding Lan,Dai Tianming,Guo Jiayin,Dai Renke,Chang Yu

Funder

Guangdong Science and Technology Planning Founding

Guangdong Province High-tech Industry Development Zone Special funds for the development of guidance

Research foundation of Education Bureau of Hunan Province, China

Zhongshan Introducing Talent Award

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference30 articles.

1. Hypertrophic cardiomyopathy;Maron;Lancet,2013

2. Hypertrophic cardiomyopathy;Ommen;Curr. Probl. Cardiol.,2011

3. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC);Elliott;Eur. Heart J.,2014

4. Mixed-lineage kinase control of JNK and p38 MAPK pathways;Gallo;Nat. Rev. Mol. Cell Biol.,2002

5. Identification and characterization of a novel MAP kinase kinase kinase, MLTK;Gotoh;J. Biol. Chem.,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiomyopathies in China: A 2018–2019 state-of-the-art review;Chronic Diseases and Translational Medicine;2020-12

2. Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation;Pharmacology & Therapeutics;2020-03